REVIEW ON PICK´S DISEASE

Authors

  • K. Shanmugapriya
  • Dr.S. Kameshwaran
  • S. Shameem
  • K.P. Sathish
  • A. saranya

DOI:

https://doi.org/10.37591/(rrjops).v14i1.1287

Keywords:

Neurodegenerative Disease, progressive supranuclear palsy, Motor Neuron Disease, Progressive Supranuclear Palsy.

Abstract

Pick´s disease is a serious clinicopathological condition that causes the frontotemporal lobe to atrophy circumferentially. Frontotemporal lobar degeneration (FTLD) is now the clinical diagnosis for patients with dementia who have frontotemporal atrophy. FTLD with TDP-43-positive inclusions, corticobasal degeneration, progressive supranuclear palsy, basophilic inclusion body disease, neuronal intermediate filament inclusion disease, and argyrophilic grain disease are additional underlying diseases in FTLD patients.

Author Biography

  • K. Shanmugapriya
    Department of pharmacology, SSM college of pharmacy, Jambai, Erode, Tamilnadu.

References

.Olney NT, Spina S, Miller BL. Frontotemporal Dementia. Neurol Clin. 2017 May;35(2):339-374.

.Hofmann JW, Seeley WW, Huang EJ, Kubota M (24 January 2019). “RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration”. Annual Review of Pathology. 14: 469–495. Doi:10.1146/annurev-pathmechdis-012418-012955. PMC 6731550. PMID : 30355151.

.Rabinovici GD, Miller BL (May 2010). “Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management”. CNS Drugs. 24 (5): 375–98. Doi:10.2165/11533100-000000000-00000. PMC 2916644. PMID 20369906.

. Paulsen JS, Gehl C. Neuropsychology. In: Jankovic J, Mazziotta JC, Pomeroy SL, Newman NJ, eds. Bradley and Daroff’s Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 44.

.McKhann, G. M., M. S.Albert, M.Grossman, B.Miller, D.Dickson, and J. Q.Trojanowski. Clinical and pathological diagnosis of frontotemporal dementia: report of the work group on frontotemporal dementia and Pick’s disease.Arch Neurol2001. 58:1803–1809.

.Bird, T. D. Genotypes, phenotypes, and frontotemporal dementia: take your pick. Neurology 1998. 50:1527–1528.

.Onyike CU, Diehl-Schmid J. The epidemiology of frontotemporal dementia. Int Rev Psychiatry. 2013 Apr;25(2):130-7.

. Cardarelli R, Kertesz A, Knebl JA (December 2010). “Frontotemporal dementia: a review for primary care physicians”. Am Fam Physician. 82 (11): 1372–7. PMID 21121521.

.Rabinovici GD, Miller BL (May 2010). “Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management”. CNS Drugs. 24 (5): 375–98. Doi:10.2165/11533100-000000000-00000. PMC 2916644. PMID 20369906.

.Snowden JS, Neary D, Mann DM (February 2002). “Frontotemporal dementia”. Br J Psychiatry. 180 (2): 140–3. Doi:10.1192/bjp.180.2.140. PMID 1182332.

Published

2023-07-26

Issue

Section

Review Article